Dror Raviv

Exoprother Medical is an Israeli company that focuses on developing a cancer treatment inspired by evolution. The company is based in Yokne'am Illit, Israel. The company targets the p53 based tumor suppression mechanism that is mutated in over 60%% of cancers, including glioblastoma, colon, bladder, ovarian, and small cell lung cancers. The company uses exosomes, natural nano-particles produced by most living cells, to deliver healthy p53 and restore the body's natural tumor suppression function with minimal adverse side-effects. Exoprother Medical was founded by Lana Volokh and Alex Tendler, and Lana Volokh has been the CEO since incorporation.

Exoprother Medical is an Israeli company that focuses on developing a cancer treatment inspired by evolution. The company is based in Yokne'am Illit, Israel. The company targets the p53 based tumor suppression mechanism that is mutated in over 60%% of cancers, including glioblastoma, colon, bladder, ovarian, and small cell lung cancers. The company uses exosomes, natural nano-particles produced by most living cells, to deliver healthy p53 and restore the body's natural tumor suppression function with minimal adverse side-effects. Exoprother Medical was founded by Lana Volokh and Alex Tendler, and Lana Volokh has been the CEO since incorporation.

Exoprother Medical is an Israeli company that focuses on developing a cancer treatment inspired by evolution. The company is based in Yokne'am Illit, Israel. The company targets the p53 based tumor suppression mechanism that is mutated in over 60%% of cancers, including glioblastoma, colon, bladder, ovarian, and small cell lung cancers. The company uses exosomes, natural nano-particles produced by most living cells, to deliver healthy p53 and restore the body's natural tumor suppression function with minimal adverse side-effects. Exoprother Medical was founded by Lana Volokh and Alex Tendler, and Lana Volokh has been the CEO since incorporation.